Washington University School of Medicine: all 1,795 studies

Page 10 of 18. Open to participants first (270), then studies with results posted, then the rest; newest registration first within each.

• Resettled Refugee Families for HealingActive, not recruitingNCT06176638Not applicable
• Choline to Improve Malnutrition and Enhance CognitionActive, not recruitingNCT06154174Not applicable
• Deimplementing CXR After CVC (DRAUP) in the ICUCompletedNCT06146348Not applicable
• Using Interventional Informatics to Address Social Determinants of Health During Clinical Care Visits to Promote Behavior Change and PREVENT Cardiovascular DiseaseCompletedNCT06121193Not applicable
• Intranasal Ketorolac TrialTerminatedNCT06083571Phase 2
• Safety and Efficacy of Novel Combination Regimens for Treatment of OnchocerciasisActive, not recruitingNCT06070116Phase 2
• TruGraf Liver Gene Expression Serial TestTerminatedNCT06061341
• Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods StudyCompletedNCT06053203
• The Perinatal Synergistic Multi-component Intervention to alLeviate dEpressive Symptoms. A Case SeriesWithdrawnNCT06048263Phase 2/3
• Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)Active, not recruitingNCT06040320Phase 1/2
• Multi-modal Imaging of Myofascial PainCompletedNCT06036524Not applicable
• Pill Bottle vs Reminder AppCompletedNCT06034301Not applicable
• Actions For Collaborative Community Engaged Strategies for HPVCompletedNCT06010108Not applicable
• Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With ObesityWithdrawnNCT06009653Phase 4
• Eggs for Gut HealthCompletedNCT06002438Not applicable
• Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping BehaviorsTerminatedNCT05994209Phase 1
• Examining Racial and Socioeconomic Differences in Chronic Low Back PainActive, not recruitingNCT05991440
• Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell CarcinomaActive, not recruitingNCT05980000Phase 2
• Providing Cancer Care Closer to Home for Patients With Multiple MyelomaTerminatedNCT05971056Not applicable
• Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among YouthActive, not recruitingNCT05965245Not applicable
• Online Peri-operative Education Program for Patients Undergoing Major Head & Neck SurgeryWithdrawnNCT05954676Not applicable
• Improving Cognition and Gestational Duration With Targeted NutritionActive, not recruitingNCT05949190Not applicable
• Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary SyndromeActive, not recruitingNCT05944562Phase 1
• Translating ECHOS2 Into an mHealth PlatformCompletedNCT05923242Not applicable
• Radical Openness for Adolescents PilotCompletedNCT05913557Early Phase 1
• Dasatinib Plus Quercetin for Accelerated Aging in Mental DisordersActive, not recruitingNCT05838560Phase 2
• Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton TherapyActive, not recruitingNCT05831579Not applicable
• Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaWithdrawnNCT05829460Phase 2
• ADI-PEG20, Obesity and PrediabetesWithdrawnNCT05829239Phase 2
• AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine CancerWithdrawnNCT05826015Phase 1
• Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplantWithdrawnNCT05820763Phase 2
• Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue SarcomaTerminatedNCT05813327Phase 1
• Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline CallersCompletedNCT05812599Not applicable
• Gut Microbiome and DepressionTerminatedNCT05808101
• ATI-2231 in Advanced Solid Tumor MalignanciesWithdrawnNCT05791474Phase 1
• Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)CompletedNCT05790252Phase 3
• Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)CompletedNCT05789316Not applicable
• Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung CancerCompletedNCT05785845Not applicable
• Biofeedback vs Laryngeal Control Therapy in Management of Paradoxical Vocal Fold MotionCompletedNCT05770518Not applicable
• Identification and Prevention of Pelvic Floor Dysfunction in Gynecologic Cancer SurvivorsTerminatedNCT05769062Not applicable
• Patient-centered Educational Material to Improve Colposcopy AdherenceCompletedNCT05762757Not applicable
• Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated GlioblastomaActive, not recruitingNCT05743595Phase 1
• Puberty, Sex Hormones and Pain Sensitivity in Adolescents With MigraineActive, not recruitingNCT05738213Not applicable
• Early Outcomes of MAKO Medial Unicompartmental Knee ArthroplastyActive, not recruitingNCT05736601
• Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer DiseaseActive, not recruitingNCT05731440
• Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)CompletedNCT05716542Not applicable
• Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance InhalersCompletedNCT05689983Phase 1/2
• Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT05678348Early Phase 1
• Psilocybin for Major Depressive DisorderWithdrawnNCT05675800Phase 2
• Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and MortalityCompletedNCT05631067Not applicable
• Myocardial Perfusion Imaging Galmydar Rest/StressCompletedNCT05625490Early Phase 1
• Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)CompletedNCT05618301Phase 1
• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung CancersTerminatedNCT05616624Phase 1/2
• Online Educational Tool for Caregivers of Pediatric Oncology PatientsCompletedNCT05616572Not applicable
• Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education ProgramWithdrawnNCT05602896Not applicable
• PET Synaptogenesis After Psilocybin In DEpression RecoveryWithdrawnNCT05601648Phase 2
• Suubi+Adherence4YouthActive, not recruitingNCT05600621Not applicable
• Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated DysomsiaWithdrawnNCT05542095Phase 1
• Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion DetectionTerminatedNCT05513027Not applicable
• Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for EpilepsyStatus unknownNCT05512130Early Phase 1
• GI Organ Tracking Via Balloon ApplicatorsWithdrawnNCT05471401Not applicable
• R21 Roche: 3-Way Tau Tracers in ADActive, not recruitingNCT05464368Phase 1
• Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell LymphomaActive, not recruitingNCT05464329Phase 1
• PET Imaging Study of α7 and α4β2-nAChR in SchizophreniaTerminatedNCT05462340Phase 1
• Protein Sources Urinary Stone RiskStatus unknownNCT05460247Not applicable
• Behavioral Plant-Based Dietary Intervention in LatinosWithdrawnNCT05444595Not applicable
• Cannabis, HIV and Mental Processing SystemsCompletedNCT05430490
• Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation TherapyCompletedNCT05427214Not applicable
• Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell LymphomaActive, not recruitingNCT05412290Phase 1
• Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic LeukemiaTerminatedNCT05410574Not applicable
• Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular LymphomaActive, not recruitingNCT05410418Phase 2
• Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant GliomasCompletedNCT05393258Not applicable
• Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic MalignanciesSuspendedNCT05377827Phase 1
• Suubi4StrongerFamiliesActive, not recruitingNCT05368714Not applicable
• THRIVE Feasibility TrialCompletedNCT05346588Phase 3
• Assessing Satisfaction With Contraceptive Counseling Using Telephone Versus Video Telehealth VisitsCompletedNCT05317468Not applicable
• M-Suubi: A Multi-Level Integrated Intervention to Reduce the Impact of HIV StigmaActive, not recruitingNCT05307250Not applicable
• Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject OpioidsCompletedNCT05300581Not applicable
• Utilizing Social Contacts to Facilitate Mammogram Screening Among African American WomenCompletedNCT05275361Not applicable
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Active, not recruitingNCT05269394Phase 2/3
• A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer SurvivorsCompletedNCT05265715Not applicable
• Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)WithdrawnNCT05255666Phase 2
• Samaki Salama: Small-scale Fisheries for Healthy Nutrition and EcosystemsStatus unknownNCT05254444Not applicable
• Evolutionary Nutrition Pilot: Enhancing Fetal Growth and Brain DevelopmentActive, not recruitingNCT05242224Not applicable
• Community-based CBT and T2D in Latino PopulationWithdrawnNCT05222373Not applicable
• Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 ParosmiaWithdrawnNCT05216614Phase 2
• RYSE Family-based Behavioral Treatment for Childhood ObesityActive, not recruitingNCT05212155Not applicable
• Interhemispheric Connectivity and CompensationCompletedNCT05207878Not applicable
• Online Self-Compassion Course for pALS (Compassion pALS)CompletedNCT05202743
• Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung CancerActive, not recruitingNCT05183932
• Pain Sensitivity During PubertyCompletedNCT05145595Not applicable
• Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to SurgeryCompletedNCT05111353Phase 1
• Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance InhalersActive, not recruitingNCT05111262Phase 1/2
• Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Cone Beam Computed Tomography-Guided On-Table Adaptive Planning in a Novel Ring Gantry Radiotherapy DeviceCompletedNCT05096286Not applicable
• DM DEVICE DISRUPTION SURVEYStatus unknownNCT05050019
• Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)TerminatedNCT05049863Phase 1
• Imaging Apoptosis for Lymphoma Treatment ResponseTerminatedNCT05048732Early Phase 1
• Duvelisib Following Chimeric Antigen Receptor T-Cell TherapyActive, not recruitingNCT05044039Phase 1
• Perioperative Outcome Risk Assessment With Computer Learning EnhancementCompletedNCT05042804Not applicable
• Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1Active, not recruitingNCT05030441Phase 2

← Washington University School of Medicine overview and focus areas